查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1666189

全球醫療機器人市場 - 2025 至 2033 年

Global Medical Robotics Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球醫療機器人市場規模達到 159.5 億美元，預計到 2033 年將達到 613.3 億美元，2025-2033 年預測期內的複合年成長率為 16.2%。

醫療機器人是指醫療保健領域用於執行、協助或增強醫療程序和醫療保健服務的機器人技術。這些機器人可以是自主的、半自主的或遠端控制的，旨在提高廣泛醫療應用的精確度、效率、安全性和結果。醫療機器人用於手術、復健、診斷和病人護理，它們通常整合人工智慧（AI）、機器學習、電腦視覺和電信系統等尖端技術。

醫療機器人市場的市場需求正在快速成長，其促進因素包括慢性病盛行率不斷上升以及微創手術需求不斷成長等。隨著技術的不斷進步，醫療保健領域對機器人系統的需求持續上升。例如，2024 年 8 月，強生醫療科技宣布 DePuy Synthes 推出了一款名為 VELYS 主動機器人輔助系統 (VELYS SPINE) 的系統，該系統已獲得美國食品藥品監督管理局 (FDA) 的 510(k) 批准，旨在用於規劃和實施骶椎、胸腰椎和髂頸椎的脊椎融合手術。

市場動態：

促進因素與約束因素

人工智慧（AI）與機器學習的融合

人工智慧（AI）和機器學習的融合極大地推動了醫療機器人市場的成長，預計將在預測期內推動市場發展。人工智慧和機器學習演算法使機器人系統能夠以更高的準確性和一致性執行手術。人工智慧能夠分析患者特定資料（例如病史和影像掃描），從而確保針對每個人最佳化手術程序，減少人為錯誤的可能性。

例如，2024 年 7 月，美敦力為 Touch Surgery 數位科技生態系統推出了新的直播功能。 Touch Surgery Live Stream 包含 14 種新的 AI 演算法，旨在增強其在術後分析中的數位能力。這些演算法為腹腔鏡和機器人輔助手術提供了人工智慧手術見解。

人工智慧可以處理來自感測器、攝影機和診斷工具的即時資料，以監測患者的生命徵象和手術進展。此功能使機器人能夠預測和適應不可預見的挑戰，即時最佳化程式。例如，美敦力公司的 Mazor X 是一款由人工智慧驅動的機器人脊椎手術系統，它利用機器學習來分析術前影像（如 CT 掃描和 MRI）並規劃最佳手術方法。然後，它根據手術期間收集的即時資料調整程序，提高脊椎手術的準確性。

機器人系統成本高

醫療機器人的高成本是嚴重阻礙市場廣泛應用和成長的主要因素之一。雖然這些系統提供了相當多的好處，但前期投資、維護成本和相關費用使得小型醫院和醫療保健提供者難以採用它們，特別是在資源匱乏的環境中。

醫療機器人系統，尤其是先進的手術機器人，初始購買價格相當高。這些系統的成本可能高達數百萬美元，許多醫院，特別是發展中國家或規模較小的醫院，難以負擔。例如，達文西手術系統是用於微創手術的最知名的機器人系統之一，其成本可能超過 200 萬美元，這還不包括年度服務費用。此外，還有訓練、維護和軟體升級的成本。

除了購買價格外，機器人系統的維護和運作成本也相當大。這些成本包括年度維護合約、校準、培訓和軟體升級，所有這些都構成了擁有和操作醫療機器人的總費用。例如，Intuitive Surgical da Vinci 系統每年的維護費用高達 10 萬至 20 萬美元。這還不包括機器人儀器更換的額外費用（每次手術費用為 1,500 至 2,000 美元）。

目錄

第1章：市場介紹和範圍

  • 報告目標
  • 報告範圍和定義
  • 報告範圍

第 2 章：高階主管見解與關鍵要點

  • 市場亮點和戰略要點
  • 主要趨勢和未來預測
  • 按產品類型分類
  • 按組件截取片段
  • 按應用程式截取的程式碼片段
  • 最終用戶的程式碼片段
  • 按地區分類

第 3 章：動態

  • 影響因素
    • 驅動程式
      • 人工智慧（AI）與機器學習的融合
    • 限制
      • 機器人系統成本高
    • 機會
    • 影響分析

第4章：戰略洞察與產業展望

  • 市場領導者和先驅者
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的成熟領導者
    • 擁有成熟產品的市場領導者
  • CXO 觀點
  • 最新進展與突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT 分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態
  • 關鍵意見領袖

第 5 章：醫療機器人市場（依產品類型）

  • 手術機器人
  • 復健機器人
  • 非侵入性放射外科機器人
  • 機器人手術器械
  • 遠端臨場機器人
  • 其他

第 6 章：醫療機器人市場（按組件分類）

  • 硬體
  • 軟體
  • 服務
  • 控制系統

第 7 章：醫療機器人市場（按應用）

  • 骨科
  • 神經病學
  • 心臟病學
  • 婦科
  • 一般外科
  • 復健與物理治療
  • 腫瘤學
  • 其他

第 8 章：醫療機器人市場（以最終用戶分類）

  • 醫院
  • 門診手術中心
  • 復健中心
  • 研究與學術機構
  • 家庭護理設置
  • 其他

第 9 章：醫療機器人市場，按區域市場分析和成長機會

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 10 章：競爭格局與市場定位

  • 競爭概況和主要市場參與者
  • 市佔率分析與定位矩陣
  • 策略夥伴關係、併購
  • 產品組合和創新的關鍵發展
  • 公司基準化分析

第 11 章：公司簡介

  • Stryker Corporation
    • 公司概況
    • 產品組合和描述
    • 財務概覽
    • 主要進展
    • SWOT 分析
  • Medtronic plc
  • Zimmer Biomet
  • Smith+Nephew
  • Globus Medical
  • Becton, Dickinson and Company
  • Johnson & Johnson
  • Intuitive Surgical
  • Diligent Robotics Inc.
  • Ronovo Surgical

第 12 章：假設與研究方法

  • 資料收集方法
  • 數據三角測量
  • 預測技術
  • 數據驗證和確認

第 13 章：附錄

簡介目錄
Product Code: MD824

The global medical robotics market reached US$ 15.95 billion in 2024 and is expected to reach US$ 61.33 billion by 2033, growing at a CAGR of 16.2% during the forecast period 2025-2033.

Medical robotics refers to robotic technology in healthcare for performing, assisting or enhancing medical procedures and healthcare services. These robots can be autonomous, semi-autonomous or remotely controlled, and they are designed to improve the precision, efficiency, safety and outcomes of a wide range of medical applications. Medical robots are used in surgeries, rehabilitation, diagnostics and patient care, and they often integrate cutting-edge technologies such as artificial intelligence (AI), machine learning, computer vision and telecommunication systems.

The market demand for the medical robotics market is growing rapidly, driven by several factors ranging from the increasing prevalence of chronic diseases to the growing need for minimally invasive surgeries. As advancements in technology continue, the demand for robotic systems in healthcare continues to rise. For instance, in August 2024, Johnson & Johnson MedTech announced that DePuy Synthes launched a system called the VELYS Active Robotic-Assisted System (VELYS SPINE), which received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and is intended for use in planning and instrumenting spinal fusion procedures in the cervical, thoracolumbar and sacroiliac spine.

Market Dynamics: Drivers & Restraints

Integration of Artificial Intelligence (AI) & Machine Learning

The integration of artificial intelligence (AI) and machine learning is significantly driving the growth of the medical robotics market and is expected to drive the market over the forecast period. AI and machine learning algorithms enable robotic systems to perform surgeries with increased accuracy and consistency. The ability of AI to analyze patient-specific data (e.g., medical history and imaging scans) ensures that the surgical procedure is optimized for each individual, reducing the chances of human error.

For instance, in July 2024, Medtronic launched its new Live Stream function for the Touch Surgery ecosystem of digital technologies. Touch Surgery Live Stream includes 14 new AI algorithms that are designed to enhance its digital capabilities within post-operative analysis. The algorithms deliver AI-powered surgical insights for laparoscopic and robotic-assisted surgery.

AI can process real-time data from sensors, cameras and diagnostic tools to monitor patient vitals and surgical progress. This capability allows the robot to predict and adapt to unforeseen challenges, optimizing the procedure in real time. For instance, Mazor X by Medtronic, an AI-driven robotic spine surgery system, utilizes machine learning to analyze preoperative images (like CT scans and MRIs) and plan the optimal surgical approach. It then adjusts the procedure based on real-time data collected during surgery, improving spinal surgery accuracy.

High Cost of Robotic Systems

The high cost of medical robotics is one of the major factors that significantly hampers the widespread adoption and growth of the market. While these systems offer considerable benefits, the upfront investment, maintenance costs, and associated expenses make them difficult for smaller hospitals and healthcare providers to adopt, especially in low-resource settings.

Medical robotic systems, especially advanced surgical robots, come with a hefty initial purchase price. These systems can cost millions of dollars, making it difficult for many hospitals, particularly those in developing countries or smaller facilities, to afford them. For instance, the da Vinci Surgical System, one of the most well-known robotic systems used for minimally invasive surgeries, can cost over $2 million, not including annual service costs. Additionally, there are costs for training, maintenance, and software upgrades.

In addition to the purchase price, the maintenance and operation costs of robotic systems are substantial. These costs involve annual maintenance contracts, calibration, training, and software upgrades, all of which contribute to the total expense of owning and operating a medical robot. For instance, the Intuitive Surgical da Vinci system requires annual maintenance that can cost up to $100,000 to $200,000 per year. This doesn't include additional costs for robotic instrument replacements (which can cost $1,500 to $2,000 per procedure).

Segment Analysis

The global medical robotics market is segmented based on product type, component, application, end-user and region.

Product Type:

The surgical robots segment is expected to dominate the medical robotics market share

The surgical robots segment is the dominant and fastest-growing segment within the medical robotics market, driven by significant advancements in minimally invasive procedures, precision surgery and robotic-assisted surgeries. This segment includes systems that are designed to assist in a wide range of surgeries, from general surgery to orthopedic, urological, cardiac surgeries and other surgeries. Minimally invasive surgery involves smaller incisions, less blood loss, faster recovery times and reduced risk of infection compared to traditional open surgeries. Surgical robots enable surgeons to perform these complex procedures with greater precision and control, making them a preferred choice.

For instance, in September 2024, THINK Surgical, Inc., received TMINI Miniature Robotic System 510(k) clearance from the U.S. Food and Drug Administration (FDA) for use with the Persona The Personalized Knee System from Zimmer Biomet. "TMINI addresses surgeon demand for ergonomic, wireless, handheld robotic systems and we believe this will accelerate the adoption of robotics in knee procedures, particularly in the outpatient setting.

As the demand for complex surgeries rises, so does the need for robotic assistance. Surgical robots offer enhanced precision, reducing the risk of human error during intricate procedures, which is particularly important in delicate surgeries like neurosurgery, orthopedic and spinal surgery. For instance, according to the National Institute of Health, globally, a staggering 310 million major surgeries are performed each year, around 40 to 50 million in the USA and 20 million in Europe. This rising surgical procedures accelerating the demand for surgical robots for better patient outcomes.

Geographical Analysis

North America is expected to hold a significant position in the medical robotics market share

The use of robotic-assisted surgeries has increased dramatically in North America especially in the United States, further solidifying the region's leadership in the medical robotics market. Robotic surgery is especially popular in areas like urology, orthopedics, cardiothoracic and neurosurgery. For instance, the da Vinci Surgical System is now commonly used for prostate cancer surgeries in the U.S., with roughly three out of four prostate cancer surgeries in the U.S. performed using da Vinci Surgery.

North America leads the world in the research and development of medical robotics, with numerous companies and academic institutions investing heavily in the advancement of robotic technologies. Innovations in areas like robotic-assisted surgery, rehabilitation robotics, and robotic diagnostics have propelled the region's dominance. Companies like Intuitive Surgical, Medtronic, and Johnson & Johnson have heavily invested in robotic surgery platforms. Intuitive Surgical, for instance, spends a significant portion of its annual revenue on R&D to improve its da Vinci surgical robots.

For instance, in March 2024, Intuitive announced that the U.S. Food and Drug Administration (FDA) provided 510(k) clearance for da Vinci 5, the company's next-generation multiport robotic system. Da Vinci 5 builds on Intuitive's da Vinci Xi's highly functional design, which surgeons and care teams around the world have used in more than 7 million procedures to date.

The rising number of surgical procedures in the region particularly in the United States is driving the demand for surgical robotics. For instance, according to the Centers for Disease Control and Prevention, in the United States, a total number of 51.4 million inpatient surgical procedures are performed, which further boosts the demand for robotics in the region.

Asia-Pacific is growing at the fastest pace in the medical robotics market

The increasing demand for minimally invasive surgeries, where robotic systems can significantly reduce recovery times and improve surgical outcomes. As the APAC population faces chronic conditions such as cancer, cardiovascular disease and musculoskeletal disorders, the demand for robotic surgeries has surged in the region, which focuses on the development of advanced medical robotics.

For instance, in December 2024, Fortis Escorts launched a next-generation surgical robot. A cutting-edge piece of medical technology, the surgical robot helps perform intricate procedures with more control and accuracy. By enabling minimally invasive operations that promise quicker recovery periods, a lower risk of complications, and better overall patient outcomes, this robot marks a substantial development in robotic-assisted surgery.

Additionally, in June 2024, SS Innovations launched SSI Mantra 3, enabling affordable access to the next-generation surgical innovation. It achieved a historic feat in Indian medical science by completing India's maiden human trial in telesurgery. The Mantra 3 is designed to enhance surgical precision, efficiency and patient outcomes. It features 5 slimmer robotic arms and an immersive 3D HD headset that provides surgeons with unmatched optics and a vision cart that provides 3D 4K vision to the entire team for precision and control. Additionally, its cost-effective pricing aims to make advanced surgical technologies more accessible to healthcare institutions across India and globally.

Competitive Landscape

The major global players in the medical robotics market include Stryker Corporation, Medtronic plc, Zimmer Biomet, Smith+Nephew, Globus Medical, Becton, Dickinson and Company, Johnson & Johnson, Intuitive Surgical, Diligent Robotics Inc., Ronovo Surgical and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global medical robotics market report delivers a detailed analysis with 70 key tables, more than 74 visually impactful figures, and 186 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Component
  • 2.5. Snippet by Application
  • 2.6. Snippet by End-User
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Integration of Artificial Intelligence (AI) & Machine Learning
    • 3.1.2. Restraints
      • 3.1.2.1. High Cost of Robotic Systems
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Force Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. Medical Robotics Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Surgical Robots*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Rehabilitation Robots
  • 5.4. Non-invasive Radiosurgery Robots
  • 5.5. Robotic Surgical Instruments
  • 5.6. Telepresence Robots
  • 5.7. Others

6. Medical Robotics Market, By Component

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 6.1.2. Market Attractiveness Index, By Component
  • 6.2. Hardware*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Software
  • 6.4. Services
  • 6.5. Control Systems

7. Medical Robotics Market, By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Orthopedics*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Neurology
  • 7.4. Cardiology
  • 7.5. Gynecology
  • 7.6. General Surgery
  • 7.7. Rehabilitation and Physical Therapy
  • 7.8. Oncology
  • 7.9. Others

8. Medical Robotics Market, By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Ambulatory Surgical Centers
  • 8.4. Rehabilitation Centers
  • 8.5. Research and Academic Institutes
  • 8.6. Home Care Settings
  • 8.7. Others

9. Medical Robotics Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
      • 9.2.7.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Brazil
      • 9.4.7.2. Argentina
      • 9.4.7.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. Stryker Corporation*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
    • 11.1.5. SWOT Analysis
  • 11.2. Medtronic plc
  • 11.3. Zimmer Biomet
  • 11.4. Smith+Nephew
  • 11.5. Globus Medical
  • 11.6. Becton, Dickinson and Company
  • 11.7. Johnson & Johnson
  • 11.8. Intuitive Surgical
  • 11.9. Diligent Robotics Inc.
  • 11.10. Ronovo Surgical

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us